Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada
· Delayed Price · Currency is CAD 0.1700
-0.0150 (-8.11%)
Apr 25, 2025, 12:12 PM EDT
Rapid Dose Therapeutics Revenue
Rapid Dose Therapeutics had revenue of 501.69K CAD in the quarter ending November 30, 2024, with 114.57% growth. This brings the company's revenue in the last twelve months to 1.61M, up 53.98% year-over-year. In the fiscal year ending February 29, 2024, Rapid Dose Therapeutics had annual revenue of 1.02M with 42.06% growth.
Revenue (ttm)
1.61M
Revenue Growth
+53.98%
P/S Ratio
13.57
Revenue / Employee
n/a
Employees
n/a
Market Cap
21.84M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.55B |
| Sienna Senior Living | 893.16M |
| Trulieve Cannabis | 1.71B |
| Extendicare | 1.47B |
| Curaleaf Holdings | 1.93B |
| WELL Health Technologies | 919.69M |
| Cronos Group | 169.23M |